Reactivation of Autoimmune Hepatitis During Budesonide Monotherapy, and Response to Standard Treatment

    October 2010 in “ Journal of Hepatology
    Ansgar W. Lohse, Hannah Gil
    Studysummary This study presented a case where budesonide was insufficient to maintain remission in autoimmune hepatitis, suggesting it may be less effective than prednisolone and associated with notable steroid side effects.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →